当前位置:首页 - 行情中心 - 药康生物(688046) - 财务分析

药康生物

(688046)

  

流通市值:65.64亿  总市值:65.64亿
流通股本:4.10亿   总股本:4.10亿

药康生物(688046)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润1.10亿元,每股收益0.27元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益220104.63万元,未分配利润50021.85万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产283005.59万元,负债62900.96万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入575,576,818.48374,808,989.09170,855,596.98686,837,009.6
营业总成本446,747,545.25287,113,871.94135,710,404.13580,186,527.9
其他经营收益
营业利润120,290,164.3877,525,168.7330,673,653.95119,367,805.57
利润总额120,160,805.7977,442,220.6930,673,653.96119,214,997.94
净利润109,900,074.670,905,477.1429,980,260.4109,819,819.3
每股收益
其他综合收益-471,982.53-555,105.94-98,315.247,553,752.88
综合收益总额109,428,092.0670,350,371.229,881,945.16117,373,572.18
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计1,791,318,747.031,781,760,715.631,719,421,426.161,709,773,844.34
非流动资产:
非流动资产合计1,038,737,191.681,016,729,686.4931,542,907.09862,871,431.31
资产总计2,830,055,938.712,798,490,402.032,650,964,333.252,572,645,275.65
流动负债:
流动负债合计542,562,949.01543,757,965.56397,976,772.17371,195,620.33
非流动负债:
非流动负债合计86,446,661.1686,820,268.0891,066,227.4466,723,335.71
负债合计629,009,610.17630,578,233.64489,042,999.61437,918,956.04
所有者权益(或股东权益):
归属于母公司股东权益合计2,201,046,328.542,167,912,168.392,161,921,333.642,134,726,319.61
股东权益合计2,201,046,328.542,167,912,168.392,161,921,333.642,134,726,319.61
负债和股东权益合计2,830,055,938.712,798,490,402.032,650,964,333.252,572,645,275.65
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计532,286,911.78317,753,772.45141,686,709.44674,117,821.39
经营活动现金流出小计445,112,587.11302,488,793.84168,414,315.17583,803,561.86
经营活动产生的现金流量净额87,174,324.6715,264,978.61-26,727,605.7390,314,259.53
投资活动产生的现金流量:
投资活动现金流入小计1,745,964,074.19919,466,872.79375,409,357.781,918,676,148.34
投资活动现金流出小计2,339,423,327.691,266,130,881.5752,289,074.171,759,783,304.33
投资活动产生的现金流量净额-593,459,253.5-346,664,008.71-376,879,716.39158,892,844.01
筹资活动产生的现金流量:
筹资活动现金流入小计266,418,263.99231,699,600119,450,00097,950,000
筹资活动现金流出小计157,111,764.7381,276,424.5272,664,988.68206,894,763.94
筹资活动产生的现金流量净额109,306,499.26150,423,175.4846,785,011.32-108,944,763.94
汇率变动对现金及现金等价物的影响54,614.881,744,503.74532,829.53959,889.98
现金及现金等价物净增加额-396,923,814.7-179,231,350.88-356,289,481.27141,222,229.58
期末现金及现金等价物余额304,291,628.03521,984,091.85344,935,989.46701,215,442.73
补充资料:
现金及现金等价物的净增加额--179,231,350.88-141,222,229.58
最新报告期:2025-11-19
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华创证券郑辰0.350.430.542025-11-19
野村东方国际证券孔令岩------2025-11-04
国信证券马千里0.320.400.462025-11-04
平安证券叶寅,倪亦道0.310.390.482025-10-29
华西证券崔文亮,徐顺利0.350.420.512025-10-23
TOP↑